MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Quality of Life Improvements in Parkinson’s Disease for Those Treated with Photobiomodulation Plus Exercise: A Sham-Controlled Study

A. Saltmarche, O. Hares, A. Liebert, B. Bicknell, M. Naeser, G. Heller, J. Sykes, K. Togeretz, A. Namini, G. Herkes (Toronto, Canada)

Meeting: 2025 International Congress

Keywords: Disease-modifying strategies, Interventions, Parkinson’s

Category: Parkinson’s Disease: Clinical Trials

Objective: To assess whether exercise alone, or exercise combined with photobiomodulation (PBM) can improve the health-related quality of life (QoL) for people with Parkinson’s disease (PD).

Background: The motor, and the often more impactful non-motor symptoms of PD have an enormous effect on QoL. While the frontline PD medications, (e.g., levodopa and dopamine agonists) can suppress some motor symptoms, they have no impact on non-motor symptoms. PBM is the use of specific wavelengths of non-thermal light that modify cellular and sub-cellular processes. Small clinical trials have shown PBM can reduce both clinical motor signs and some non-motor symptoms (e.g., cognition, sense of smell) in PD. In addition, vigorous exercise, can have a positive impact on non-motor symptoms.

Method: Active PBM treatment consisted of transcranial irradiation with an LED helmet plus abdominal irradiation with a laser. Sham devices were identical but produced no light. All participants also enrolled in vigorous exercise programs during all stages.

Stage 1: double-blinded and randomized, active PBM (n=32) vs. sham PBM (n=31), 8 weeks, followed by 4 weeks no treatment.

Stage 2: all received active PBM (12 drop outs, n=51), 8 weeks, followed by 4 weeks no treatment.

Stage 3: either continued active PBM + exercise (n=17), or exercise alone (n=26), range 18 to 52 weeks, average 34 weeks

QoL data was collected by structured and unstructured participant reflections, group focus sessions and one-on-one interviews, evaluated using thematic analysis.

Results: In Stage 1, both the sham group and the active group gave equally positive accounts of their experience with the treatments. No member of the sham group was aware that they did not have active treatment. At the end of Stage 3 there was a significant difference between those who continued with PBM and those who did not, with greater improvements in QoL for the continuing group. There were accounts of declining QoL in the exercise alone group.

Conclusion: This is the largest study to date using PBM to treat PD. Both exercise alone and exercise + PBM improved reported QoL over 8 weeks. After an extended period of using PBM + exercise, there was a greater improvement in QoL when PBM was combined with exercise, compared to exercise alone.

References: (ClinicalTrials.gov: NCT06036433)

To cite this abstract in AMA style:

A. Saltmarche, O. Hares, A. Liebert, B. Bicknell, M. Naeser, G. Heller, J. Sykes, K. Togeretz, A. Namini, G. Herkes. Quality of Life Improvements in Parkinson’s Disease for Those Treated with Photobiomodulation Plus Exercise: A Sham-Controlled Study [abstract]. Mov Disord. 2025; 40 (suppl 1). https://www.mdsabstracts.org/abstract/quality-of-life-improvements-in-parkinsons-disease-for-those-treated-with-photobiomodulation-plus-exercise-a-sham-controlled-study/. Accessed October 5, 2025.
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2025 International Congress

MDS Abstracts - https://www.mdsabstracts.org/abstract/quality-of-life-improvements-in-parkinsons-disease-for-those-treated-with-photobiomodulation-plus-exercise-a-sham-controlled-study/

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • AI-Powered Detection of Freezing of Gait Using Wearable Sensor Data in Patients with Parkinson’s Disease
  • Effect of Ketone Ester Supplementation on Motor and Non-Motor symptoms in Parkinson's Disease
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Life expectancy with and without Parkinson’s disease in the general population
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Insulin dependent diabetes and hand tremor
  • Improvement in hand tremor following carpal tunnel release surgery
  • Impact of expiratory muscle strength training (EMST) on phonatory performance in Parkinson's patients
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley